T he US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to a cancer drug called dostarlimab ...
From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...
Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite ...
Omeros is putting up its monoclonal antibody up for FDA approval—again. | Omeros is putting up its monoclonal antibody up for ...
"Receiving FDA Orphan Drug Designation for azeliragon for the treatment of brain metastasis from breast cancer highlights a continued need for new treatment options for these patients," commented ...
The Breakthrough Therapy designation, which is the second for the company, provides Seres with more intensive FDA guidance and a potentially expedited review process. This comes after the drug ...
Cantex received orphan drug designation for Azeliragon from the FDA. Azeliragon targets brain metastasis from breast cancer and other cancers. Orphan drug designation offers tax credits and ...
"Receiving FDA Orphan Drug Designation for azeliragon for the treatment of brain metastasis from breast cancer highlights a continued need for new treatment options for these patients," commented ...
K92 Mining Inc. has been downgraded from a "Buy" to a "Hold" rating due to its current high share price, but concerning the business outlook, this has strengthened. The company's Kainantu Gold ...
Stoke Therapeutics, Inc. STOK announced that the FDA has granted a Breakthrough Therapy designation ... Stoke Therapeutics is currently discussing the path for a global phase III registrational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback